FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026 ) Is BPC 157 FDA approved? Latest News 2026 BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved FDA Peptide Reclassification 2026: What Researchers Want Know your risk factors This is one of the biggest peptide regulatory shifts in years. And it's just getting started. The FDA has taken its first step toward reversing its 2023 stance, removing 12 peptides from